XML 20 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (882,750) $ (22,094,947)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 3,165,980 3,136,109
Debt conversion expense 0 18,841,407
Loss by equity method investee 128,640 0
Loss on disposal of equipment 1,997 5,640
Amortization of premium on marketable securities 104,757 8,003
Share-based compensation expense 1,452,911 748,119
Amortization of discount on related party debt 0 940,923
Long term incentive plan 0 (74,404)
Deferred income taxes (80,048) 57,536
Deferred rent (32,697) 3,777
Restricted stock exchanged for taxes (17,690) (57,343)
Changes in operating assets and liabilities:    
Accounts receivable (661,770) 1,359,056
Inventories 276,090 (2,655,221)
Other current assets (279,327) 253,553
Accounts payable (90,320) 484,237
Interest payable 0 292,049
Accrued compensation (768,485) 1,609,281
Accrued liabilities, other (108,111) 270,612
Accrued pension liability (85,270) (116,395)
Deferred revenue 182,804 288,329
Net cash provided by operating activities 2,306,711 3,300,321
Cash flows from investing activities:    
Proceeds from maturity of available-for-sale-securities 15,020,000 0
Purchases of available-for-sale securities (2,438,322) (18,945,717)
Purchase of equity method investment (2,000,000) 0
Purchases of property, plant and equipment (856,875) (355,145)
Acquisition of business, net of cash acquired (181,261) 0
Net cash provided by (used in) investing activities 9,543,542 (19,300,862)
Cash flows from financing activities:    
Borrowings from line of credit 3,033,385 2,646,500
Repayments of line of credit (3,033,385) (2,646,500)
Payments of note payable (47,329) 0
Payments of secured borrowings (238,984) 0
Proceeds from exercise of stock options 9,713 0
Proceeds from sale of common stock, net 0 23,428,900
Net cash provided by (used in) financing activities (276,600) 23,428,900
Effect of exchange rates on cash and cash equivalents (33,672) (35,329)
Net increase in cash and cash equivalents 11,539,981 7,393,030
Cash and cash equivalents at beginning of period 9,369,624 1,976,594
Cash and cash equivalents at end of period 20,909,605 9,369,624
Supplemental disclosure of cash flow information:    
Cash paid during the period for income tax 284,374 42,957
Cash paid during the period for interest 13,845 62,418
Non-cash financing activities:    
Note payable issued in conjunction with acquisition of business 462,184 0
Non-cash debt and interest converted to equity $ 0 $ 25,327,441